Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
Completed · Phase 1
Conditions studied: Pneumococcal Infections
In brief
The purpose of this study is to learn whether or not giving a tetanus/diphtheria vaccination ("tetanus shot") before giving pneumococcal vaccine makes the pneumococcal vaccine more effective without causing too many side effects.
Key facts
- Study ID
- NCT00164411
- Run by
- Centers for Disease Control and Prevention
- People needed
- 30
- Starts
- 2004-01-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2012-03-14
Who can join
Age: 50 and older, up to 64. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Participation in any other investigational clinical trials except purely observational studies within 4 weeks prior to study start
- Any vaccination within 2 weeks prior to first study vaccine
- Evidence of systemic or local infection within one week prior to first study vaccine
- HIV infection
- Renal failure
- Receipt of a pneumococcal or Td vaccine within 5 years
- Current receipt of therapy for neoplastic disease
- Current receipt of immunosuppressive therapy
- Terminal illness withlife expectancy less than 3 months
Where it is running
- Emory University School of Medicine — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.